Shigella Vaccines: The Continuing Unmet Challenge
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25084329 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ti Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Pathobiology and Bond Life Science Center, University of Missouri, Columbia, MO 65201, USA. Hauptthemen laut MEDLINE: Shigella Vaccines, Dysentery, Bacillary, Shigella. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Shigellosis is a severe gastrointestinal disease that annually affects approximately 270 million individuals globally. It has particularly high morbidity and mortality in low-income regions; however, it is not confined to these regions and occurs in high-income nations when conditions allow. The ill effects of shigellosis are at their highest in children ages 2 to 5, with survivors often exhibiting impaired growth due to infection-induced malnutrition. The escalating threat of antibiotic resistance further amplifies shigellosis as a serious public health concern. This review explores Shigella pathology, with a primary focus on the status of Shigella vaccine candidates. These candidates include killed whole-cells, live attenuated organisms, LPS-based, and subunit vaccines. The strengths and weaknesses of each vaccination strategy are considered. The discussion includes potential Shigella immunogens, such as LPS, conserved T3SS proteins, outer membrane proteins, diverse animal models used in Shigella vaccine research, and innovative vaccine development approaches. Additionally, this review addresses ongoing challenges that necessitate action toward advancing effective Shigella prevention and control measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Pathobiology and Bond Life Science Center, University of Missouri, Columbia, MO 65201, USA.
- Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD 21201, USA.
ORCID-Profile: Sayan Das, Debaki R Howlader, William D Picking
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Lu, T., Das, S., Howlader, D. R., Picking, W. D., & Picking, W. L. (2024). Shigella Vaccines: The Continuing Unmet Challenge. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084329
Vancouver
Lu T, Das S, Howlader DR, Picking WD, Picking WL. Shigella Vaccines: The Continuing Unmet Challenge. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084329
BibTeX
@article{Lu2024,
author = {Lu, Ti and Das, Sayan and Howlader, Debaki R and Picking, William D and Picking, Wendy L},
title = {Shigella Vaccines: The Continuing Unmet Challenge},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25084329}
}
EUVIMED